In that paper, the association was conjectured between lower ACE2 expression and adverse cardiometabolic health indices, including type 2 diabetes and obesity status, through increased Angiotensin II [17]. Here, ACE2 is linked to obesity due to melanocortin 4 receptor deficiency.